Biomark Capital
http://www.biomarkcapital.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Biomark Capital
Deal Watch: Lilly Teams Up With Lycia In Protein Degradation
Lilly hopes to address immunology and pain indications with biotech’s LYTAC technology. Sunovion licenses European rights to Parkinson’s therapy Kynmobi to Bial.
Medtech Execs On The Move, May 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Execs On The Move, May 2015
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Broad gets $650m for psychiatric genomic research, hopes pharma joins effort
Philanthropist Ted Stanley made a multi-year $650m commitment to fund genomic research at the Eli and Edythe L Broad Institute in collaboration with scientists around the world that may generate biological pathways and molecules that could reignite pharmaceutical company interest in schizophrenia, bipolar disorder and other psychiatric conditions.
Company Information
- Industry
- Medical Devices
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Better Doctor
- HyperMEd Imaging
- i2Dx
- Opus Bio
- Strand Life Sciences
- WhiteGlove Health
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice